About this compound
A co-lyophilized 1:1 blend of CJC-1295 (No DAC) and Ipamorelin, the two most frequently co-ordered sequences in the endocrine class.
Studied in
- Combined-protocol research
- GH/IGF-1 axis
- Receptor selectivity
Compound identity
| Compound | CJC-1295 + Ipamorelin |
|---|---|
| CAS number | 863288-34-0 / 170851-70-4 |
| Molecular formula | Co-lyophilized blend |
| Composition | Blend — component molecular weights: 3367.9 / 711.86 g/mol |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Endocrine
DUET
CJC-1295 + Ipamorelin
GHRH analog and GH secretagogue, blended for combined-protocol research.
What the research targets
Supplied as a single reconstitution for protocols that study a GHRH analog alongside a selective secretagogue.
Supply formats
Single units ship from stock. Cases are back-ordered against the same single-unit price.
Stick is newly released — available alongside the vial on every compound.
Single unit
Sample quantity — one unit.
10 mg totalVial
PS-9043831-10-MG-TOTAL
On verified accountSkinni Stick™ 10 mg totalSkinni Stick™New
Single-compound Skinni Stick™. Supplied to verified accounts only.
PS-9043831-PEN-10-MG-TOTAL
On verified account
Case — back-order
Ten of one size, at 10× volume pricing.
Case · 10 × 10 mg total
Back-order — 15% off the single-unit price.
PS-9043831-C10-10-MG-TOTAL
On verified accountCase · 10 × Skinni Stick™ 10 mg totalNew
Back-order — 15% off the single-unit price.
PS-9043831-C10-PEN-10-MG-TOTAL
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
Research use only
This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.
From the research library
Cited summaries of the published work behind CJC-1295 + Ipamorelin — what was studied, in which model, and what was measured.
More in Endocrine
LONGWAVE
CJC-1295 (DAC)
Studied for its extended half-life relative to the no-DAC form in GH-axis research models.
PULSE
CJC-1295 (no DAC)
Studied for its short-acting pulsatile profile on the GH/IGF-1 axis in endocrine research models.
BROADSIDE
Hexarelin
Studied in growth-hormone secretagogue receptor models, including cardiac-tissue receptor research.